These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 35546405)
1. The correlation between promoter hypermethylation of VDR, CLDN, and CasR genes and recurrent stone formation. Khatami F; Gorji A; Khoshchehreh M; Mashhadi R; Pishkuhi MA; Khajavi A; Shabestari AN; Aghamir SMK BMC Med Genomics; 2022 May; 15(1):109. PubMed ID: 35546405 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in CaSR and CLDN14 Genes Associated with Increased Risk of Kidney Stone Disease in Patients from the Eastern Part of India. Guha M; Bankura B; Ghosh S; Pattanayak AK; Ghosh S; Pal DK; Puri A; Kundu AK; Das M PLoS One; 2015; 10(6):e0130790. PubMed ID: 26107257 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet. Uchiyama T; Tatsumi N; Kamejima S; Waku T; Ohkido I; Yokoyama K; Yokoo T; Okabe M Hum Cell; 2016 Oct; 29(4):155-61. PubMed ID: 27589858 [TBL] [Abstract][Full Text] [Related]
4. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas. Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients. Ferreira LG; Pereira AC; Heilberg IP Nephron Clin Pract; 2010; 114(2):c135-44. PubMed ID: 19887834 [TBL] [Abstract][Full Text] [Related]
12. [GENETIC RISK FACTORS FOR MULTIPLE KIDNEY STONE FORMATION IN THE RUSSIAN POPULATION]. Apolihin OI; Sivkov AV; Konstantinova OV; Slominskij PA; Tupicyna TV; Kalinichenko DN Urologiia; 2015; (4):4-6. PubMed ID: 26665756 [TBL] [Abstract][Full Text] [Related]
13. Coding region analysis of vitamin D receptor gene and its association with active calcium stone disease. Basiri A; Shakhssalim N; Houshmand M; Kashi AH; Azadvari M; Golestan B; Mohammadi Pargoo E; Pakmanesh H Urol Res; 2012 Feb; 40(1):35-40. PubMed ID: 21814771 [TBL] [Abstract][Full Text] [Related]
15. Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3. Fetahu IS; Höbaus J; Aggarwal A; Hummel DM; Tennakoon S; Mesteri I; Baumgartner-Parzer S; Kállay E Int J Cancer; 2014 Nov; 135(9):2014-23. PubMed ID: 24691920 [TBL] [Abstract][Full Text] [Related]
16. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results]. Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098 [TBL] [Abstract][Full Text] [Related]
17. Association between calcium-sensing receptor gene polymorphisms and recurrent calcium kidney stone disease: a comprehensive gene analysis. Shakhssalim N; Kazemi B; Basiri A; Houshmand M; Pakmanesh H; Golestan B; Eilanjegh AF; Kashi AH; Kilani M; Azadvari M Scand J Urol Nephrol; 2010 Dec; 44(6):406-12. PubMed ID: 20602573 [TBL] [Abstract][Full Text] [Related]
18. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail. Bai S; Wang H; Shen J; Zhou R; Bushinsky DA; Favus MJ J Bone Miner Res; 2010 Apr; 25(4):830-40. PubMed ID: 19929616 [TBL] [Abstract][Full Text] [Related]
19. Genetic variants in the promoter region of the calcium-sensing receptor gene are associated with its down-regulation in neuroblastic tumors. Masvidal L; Iniesta R; García M; Casalà C; Lavarino C; Mora J; de Torres C Mol Carcinog; 2017 Apr; 56(4):1281-1289. PubMed ID: 27862333 [TBL] [Abstract][Full Text] [Related]
20. Association of TRPV5, CASR, and CALCR genetic variants with kidney stone disease susceptibility in Egyptians through main effects and gene-gene interactions. Ali FT; El-Azeem EMA; Hekal HFA; El-Gizawy MM; Sayed MS; Mandoh AY; Soliman AF Urolithiasis; 2022 Dec; 50(6):701-710. PubMed ID: 36088585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]